AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2014
Feb 18, 2014
34152_dirs_2014-02-18_f891a466-21a7-48f9-b8ae-bfd54b56dc93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2014-02-18
Reporting Person: Kirk Julian P. (Director)
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23